This site is intended for U.S. healthcare professionals.

Translating mRNA
Educational Webinar Series

The Pfizer Vaccines US Medical Affairs Team invites you to attend an educational webinar series titled Translating mRNA, which is focused on providing education on COVID-19 and vaccination. The webinar series is designed to communicate scientific information which may include recent study results to help inform healthcare providers regarding Pfizer and BioNTech COVID-19 vaccines and burden of disease.

We are hosting a Translating mRNA webinar on the topic below.

DATE

Thursday, 24 April 2025

TIME

12:00 pm – 12:45pm ET

From Misinformed to Informed:
Considerations for Effective Communication for
mRNA COVID-19 Vaccines

Speaker

Dr. Jessica Steier, DrPH, PMP

Dr. Jessica Steier is the founder and CEO of Unbiased Science and CEO of Vital Statistics Consulting. A public health scientist and health services researcher, she brings extensive expertise in evaluation science, public health policy, research design, biostatistics, and advanced analytics. Dr. Steier received her Doctor of Public Health degree from the City University of New York (CUNY) and her Master of Public Health in Evaluative Sciences from SUNY-Stony Brook University. She is a certified Project Management Professional (PMP) with additional certifications in Patient Safety from Johns Hopkins and COVID-19 response from both Johns Hopkins and the American Red Cross. She holds a certificate in Public Relations from Cornell University because, as she says, public health needs better PR! As the creator and host of The Unbiased Science Podcast, Dr. Steier leads the organization's mission to make scientific evidence accessible and understandable to all. Dr. Steier is particularly passionate about translating complex research for diverse audiences, drawing her inspiration from her father's example that scientific literacy should be accessible regardless of educational background.

Learning Objective:

By the end of this webinar, US healthcare provider attendees will have heard Dr. Steier share considerations around navigating some patient concerns about mRNA COVID-19 vaccines using evidence-based communication strategies that build trust, counter misinformation, and support informed decision-making.

The objectives include:

  • Recognizing common patient concerns and misconceptions
  • Considerations for articulating clear, science-based responses to myths
  • Cultivating empathetic listening and effective conversation techniques
  • Tailoring communication approaches to different patient needs
  • Building confidence in discussing vaccine technology and ingredients

This webinar will include a live question-and-answer session with Dr. Steier, along with Pfizer medical experts 

Target Audience:
US Healthcare professionals including physicians, nurse practitioners, pharmacists, and physician assistants. 
Continuing medical education credit is NOT associated with this event. 
Prior Translating mRNA Webinar Video Recordings are Available On-Demand

Indication:
COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.

Emergency Use Authorization:
Emergency uses of COVID-19 vaccines from BioNTech and Pfizer, including Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula), have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months of age and older. Emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical products under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.